Document:

Exhibit
10.1

 

CONSULTING
AGREEMENT

 

This
Agreement is made and entered into effective as of the 25th day of September, 2020, by and between ProPhase Labs, Inc.,
a Delaware corporation (the “Company”), and Predictive Laboratories, Inc., a Utah corporation (the “Consultant”).

 

In
consideration of and for the mutual promises and covenants contained herein, and for other good and valuable consideration, the
receipt of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

1.
Purpose. The Company hereby retains the Consultant during the term specified in Section 2 hereof to render consulting advice
to the Company as set forth in Section 3 hereof.

 

2.
Term. This Agreement shall be effective for a period commencing on the date hereof and expiring on September 1, 2022; provided,
however, that the Company may terminate this agreement at any time on five (5) days prior written notice.

 

3.
Duties of Consultant. During the term of this Agreement, the Consultant will provide the Company with such regular and
customary consulting advice as is reasonably requested by the Company, provided that the Consultant shall not be required to undertake
duties not reasonably within the scope of the consulting advisory service contemplated by this Agreement. In performance of these
duties, the Consultant shall provide the Company with the benefits of its best judgment and efforts. The Consultant represents
and warrants to the Company that it is experienced and competent to provide the consulting duties indicated in this Agreement
and that the Company has agreed to enter into this Agreement in reliance on this representation and warranty. The Consultant’s
duties shall include, but will not necessarily be limited to the following:

 

		 	(a)	Identifying
                                         and introducing the Company to new opportunities in the medical technology and testing
                                         fields.

 

		 	(b)	Assisting
                                         and advising the Company in acquiring one or more Clinical Laboratory Improvement Amendments
                                         (CLIA) certified labs suitable for Covid-19 and other testing (“Test Labs”),
                                         and assisting the Company in causing such Test Labs to be validated and certified to
                                         process any test kits that Consultant and Consultants’ affiliates are validated
                                         and certified to process.

 

		 	(c)	Assisting
                                         the Company in equipping and staffing Test Labs, and advising and assisting in the operation
                                         of Test Labs.

 

		 	(d)	Validating
                                         and obtaining certification of the Test Labs, including validating and certifying the
                                         Test Labs for processing of Covid-19 saliva sample collection test kits (“Test
                                         Kits”) and other test kits provided by Spectrum Solutions and other manufacturers
                                         of test kits.

 

    	 

     

    

 

		 	(e)	Assisting
                                         the Company in obtaining a flow of business, orders and revenues from multiple sources
                                         in the industry, including but not limited to at least one significant, nation-wide manufacturer
                                         and distributor of Test Kits.

 

		 	(f)	Making
                                         certain of its employees, consultants, representatives and other relationships available
                                         to the Company during normal business hours for meetings and teleconferences regarding
                                         the services contemplated in this Agreement.

 

		 	(g)	Assisting
                                         the Company with respect to other matters generally consistent with and/or related to
                                         the aforementioned items and this Agreement.

 

4.
Expenses. Each party to this Agreement shall bear its own costs and expenses in connection with entering into and performing
this Agreement.

 

5.
Compensation. Consultant shall be compensated as set forth in Schedule A annexed hereto, which is incorporated herein by
reference.

 

6.
Non-Solicitation, Confidentiality and Non-Disparagement.

 

During
the term of this Agreement and for a period of two (2) years following the effective date of the termination of this Agreement,
none of the Consultant nor any officer, director, employee or agent of the Consultant shall, directly or indirectly (a) solicit,
entice, or induce any person who presently is, or at any time during the term hereof shall be, an employee, independent contractor,
agent, director or officer of the Company or a Company affiliate to leave their position at the Company and/or become employed
by the Consultant; (b) encourage any actual or prospective customer of the Company or an affiliate of the Company to reduce the
volume of business they are conducting or planning to conduct with the Company, or divert such customer away from the Company;
(c) disclose any confidential or non-public information concerning the Company and its affiliates to third parties or use such
information for any purpose (except in providing services hereunder to the Company) without the prior written approval of the
Company; or (d) trade in the securities of the Company.

 

Except
as set forth in Section 7 below, During the term of this Agreement and for a period of two (2) years following the effective date
of the termination of this Agreement, the Company shall not directly or indirectly, solicit, entice, or induce any person who
presently is, or at any time during the term hereof shall be, an employee, independent contractor, agent, director or officer
of the Consultant or to leave their position with Consultant and become employed by the Company. It is not contemplated that Consultant
will provide the Company with confidential information concerning the Company; however, if Consultant does provide confidential,
non-public information concerning Consultant to the Company in connection with Consultant performing services pursuant to this
Agreement, for a period of two years from the effective date of the termination of this Agreement, the Company will not use or
disclose such information except for the purpose of the Company pursuing and operating the businesses and opportunities contemplated
by this Agreement.

 

    	 

     

    

 

7.
Other Agreements. The Consultant shall use commercially reasonable efforts to encourage Jack Turner to become a part-time
employee of or consultant to the Company. The parties acknowledge that (a) the terms of any employment agreement between the Company
and Jack Turner will be negotiated exclusively between the Company and Jack Turner, and (b) Jack Turner may also simultaneously
be engaged by the Consultant.

 

8.
Key Service Providers. Consultant shall assure that the following agents or employees of Consultant are assigned to provide
the services contemplated by this Agreement: Kenneth Ward, MD, Lesa Nelson and Allen Ward. Consultant may staff these projects
with additional agents or employees subject to the Company’s prior written consent, which may be granted, conditioned or
withheld in the Company’s discretion.

 

9.
Severability. Every provision of this Agreement is intended to be severable. If any term or provision hereof is deemed
unlawful or invalid for any reason whatsoever, such unlawfulness or invalidity shall not affect the validity of the remainder
of this Agreement.

 

10.
Miscellaneous.

 

		 	(a)	Any
                                         notice or other communication between the parties hereto shall be sent by certified or
                                         registered mail, postage prepaid, or by email:

 

(i)
If to the Company, to:

 

ProPhase
Labs, Inc.

621
N. Shady Retreat Road

Doylestown,
Pennsylvania 18901

Attention:
Ted Karkus, Chief Executive Officer

Email:
karkus@prophaselabs.com

 

(ii)
If to the Consultant, to:

 

Predictive
Laboratories, Inc.

2749
East Parleys Way, Suite 100

Salt
Lake City, Utah 84109

Email:
brobinson@predtechgroup.com

 

Either
party may change the foregoing address by notice given pursuant to this Section 9(a). Such notice or other communication shall
be deemed to be given on the date of mailing or transmissions via email if during normal business hours (and the next day if after
business hours).

 

		 	(b)	This
                                         Agreement has been duly authorized, executed and delivered by and on behalf of the Company
                                         and the Consultant.

 

    	 

     

    

 

 

		 	(c)	This
                                         Agreement shall be construed and interpreted in accordance with the laws of the State
                                         of Delaware, without giving effect to conflicts of laws rules of such states. Each of
                                         the parties hereto hereby agrees that any action, proceeding, or claim against it arising
                                         out of, or in any way relating to, this Agreement shall be brought and enforced exclusively
                                         in the state or federal courts located in the state of Delaware, and irrevocably submit
                                         to the exclusive jurisdiction and venue of such courts.

 

		 	(d)	Nothing
                                         herein shall constitute Consultant as an employee or agent of the Company. Consultant
                                         shall not have the authority to obligate, bind or commit the Company in any manner whatsoever.

 

		 	(e)	The
                                         provisions of Sections 4, 5, 6, 7, 9 and 10 shall survive the termination or expiration
                                         of this Agreement.

 

		 	(f)	This
                                         Agreement calls for the specialized services and experience of Consultant and therefore
                                         shall not be assignable by Consultant without the prior written consent of the Company,
                                         which consent may be granted or withheld by the Company in its discretion. Consultant
                                         is aware that Company intends to form one or more subsidiaries to pursue, operate and
                                         hold the business opportunities contemplated hereby, and Consultant consents to the assignment
                                         of this Agreement to such subsidiaries.

 

		 	(g)	This
                                         Agreement contains the entire understanding between the parties hereto with respect to
                                         the subject matter hereof and may not be modified or amended except by a writing duly
                                         signed by the party against whom enforcement of the modification or amendment is sought.
                                         No party has relied on any promise, statement or representation in entering into this
                                         Agreement except as set forth herein.

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date hereof.

 

	PROPHASE
    LABS, INC.	 
	 	 	 
	By:
	/s/
    Ted Karkus	 
	 	Ted
    Karkus, Chief Executive Officer	 
	 	 	 
	Predictive
    Laboratories, Inc.	 
	 	 	 
	By:
    	/s/
    Bradley C. Robinson	 
	 	Bradley
    C. Robinson, Chief Executive Officer 	 

 

    	 

     

    

 

SCHEDULE
A - CONSULTANT COMPENSATION

 

		1.	The
                                         parties agree that the compensation that Consultant is entitled to earn or receive pursuant
                                         to this Agreement shall be entirely based on and subject to attaining the following milestones:

 

		a.	At
                                         such time as the Company completes the acquisition of its first Test Lab that has been
                                         validated and certified to process Test Kits manufactured by Spectrum Solutions, the
                                         Consultant shall receive a consulting fee of $250,000;

 

		b.	At
                                         such time as the Company has processed 50,000 Test Kits from Spectrum Solutions, the
                                         Consultant shall receive a consulting fee of $500,000;

 

		c.	At
                                         such time as the Company has processed 50,000 Covid-19 Test Kits from a second source
                                         introduced by the Consultant (i.e., a source other than Spectrum Solutions) the
                                         Consultant shall receive a consulting fee of $250,000; and

 

		d.	The
                                         Consultant shall receive consulting fees equal to five percent (5%) of the net revenues
                                         the Company generates from processing Test Kits in the Test Labs where such revenues
                                         are from Spectrum Solutions Test Kits or from other sources introduced to the Company
                                         by the Consultant (excluding the revenues from the Test Kits set forth in sections 1b
                                         and 1c above).

 

		2.	All
                                         compensation earned by the Consultant shall be first applied to the acceleration and
                                         prepayment of all sums due to the Company, including but not limited to sums due pursuant
                                         to the Promissory Note dated September 25th, 2020, in the initial principal
                                         amount of $3,000,000, entered into by the Company, as lender, and the Consultant, as
                                         borrower (the “Note”). Consultant acknowledges that it shall not be entitled
                                         to receive any payments pursuant to this Agreement unless and until the Note has been
                                         paid in full.

 

		3.	Notwithstanding
                                         any other provision of this Agreement, Consultant acknowledges and agrees that the total
                                         compensation which the Consultant is entitled to earn or to receive pursuant to this
                                         Agreement and the transactions contemplated hereby (inclusive of amounts credited against
                                         the Note) is capped at $4,000,000.

 

		4.	The
                                         Company has not made any representations, promises or commitments to Consultant with
                                         respect to the ability of the Company to attain any of the milestones set forth in Section
                                         1 above, or as the amounts, if any, that Consultant may earn or receive pursuant to this
                                         Agreement. Consultant acknowledges that the decision of the Company whether and how to
                                         pursue any business opportunity contemplated by this Agreement shall be entirely in the
                                         discretion of the Company and the Company shall not be liable to Consultant as a consequence
                                         of any such decision. The parties expressly agree that the consummation of any transactions
                                         to use or acquire any Test Labs, testing facilities or consummate any other transaction
                                         related hereto with any third parties shall be negotiated and decided by the Company
                                         in its sole discretion.Exhibit
10.2

 

AMENDED
AND RESTATED PROMISSORY NOTE

AND
SECURITY AGREEMENT

 

	$3,000,000.00	September
    25, 2020

 

FOR
VALUE RECEIVED, the undersigned Predictive LABORATORIES, Inc., a Utah corporation
(the “Debtor”), with offices located at 2749 East Parleys Way, Suite 100, Salt Lake City, UT 84109, or at such other
place as the Debtor may designate upon written notice to the Secured Party, hereby promises to pay to the order of PROPHASE LABS,
INC., a Delaware corporation (together with its successors and assigns, the “Secured Party” or the “Holder”),
at its office located at 621 N. Shady Retreat Road, Doylestown, PA, 18901, or at such other place as the holder hereof may designate
upon written notice to the Debtor, in lawful money of the United States of America and in immediately available funds, the principal
sum of Three Million and 00/100 Dollars ($3,000,000.00) (the “Initial Principal Amount” or such lesser or greater
principal amount owed from time to time, the “Principal Amount”), plus all interest capitalized as set forth
herein plus all accrued interest thereon that has not been capitalized plus all expenses payable pursuant hereto.

 

This
Note amends and restates in its entirety (i) that certain Promissory Note and Security Agreement dated July 21, 2020 (as the same
has been amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Original
July 21 Note”), made by Debtor in favor of the Holder in the original principal amount of Seven Hundred and Fifty Thousand
and 00/100 Dollars ($750,000) and for which, as of September 25, 2020 (the “Restatement Effective Date”), the principal
amount (excluding any unpaid interest not yet accreted to principal or paid in cash) outstanding is $770,750 immediately prior
to being amended and restated hereby, and (ii) that certain Promissory Note and Security Agreement dated July 29, 2020 (as the
same has been amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Original
July 29 Note”, and together with the Original July 21 Note, the “Original Notes”), made by Debtor in favor of
the Holder in the original principal amount of Two Hundred and Fifty Thousand and 00/100 Dollars ($250,000) and for which, as
of the Restatement Effective Date, the principal amount (excluding any unpaid interest not yet accreted to principal or paid in
cash) outstanding is $256,146 immediately prior to being amended and restated hereby. The Debtor and the Holder acknowledge and
agree that upon and after giving effect to the amendment and restatement of the Original Notes hereby on the Restatement Effective
Date, a total of Three Million and 00/100 Dollars ($3,000,000.00) will be outstanding under this Note and the Original Notes shall
be deemed to be replaced by this Note. Notwithstanding the foregoing, it is expressly agreed and understood that this Note does
not extinguish the outstanding indebtedness evidenced by the Original Notes and is not intended to be a substitution or novation
of the original indebtedness, which shall continue in full force and effect except as specifically amended and restated hereby.

 

LOAN:

 

The
Secured Party hereby agrees, subject to the terms hereof and relying on the covenants, representations, and warranties herein
set forth, to make a loan to the Debtor on the date hereof (the “Closing Date”) in an aggregate amount equal to the
Initial Principal Amount (the “Loan”). Amounts advanced hereunder that are repaid may not be re-advanced.

 

    	 

     

    

 

INTEREST:

 

(a)       Interest.
Interest shall accrue on the Principal Amount and on any Principal Increases (as defined below) on the Loan at a rate per annum
equal to Applicable Rate (as defined below) from the date hereof until the repayment in full of the Principal Amount plus any
Principal Increases together with any accrued interest thereon that has not been capitalized (the “Repayment Date”).
“Applicable Rate” means (i) fifteen percent (15%) per annum, from and including the Restatement Effective Date; it
being understood that upon the occurrence and during the continuance of an Event of Default, the then Applicable Rate shall automatically
increase to the Default Rate (as defined below). Interest on this Note shall be calculated based on a 360-day year. Interest shall
be payable monthly in arrears on the first day of each month for the prior monthly period, as well as at maturity (whether upon
demand, by acceleration or otherwise) (each such date, a “Payment Date”); provided however, prior to September 1,
2021, interest shall be paid and capitalized in kind by increasing the principal amount of this Note (any such increase, a “Principal
Increase”) by an amount equal to the interest accrued on the principal amount (as increased by the Principal Increases)
during the prior month.

 

(b)       Default
Interest. From and after the maturity date of this Note, or such earlier date as all principal owing hereunder becomes due
and payable by acceleration or otherwise, or at the Secured Party’s option upon the occurrence, and during the continuance
of an Event of Default, the outstanding principal balance of this Note shall bear interest at an increased rate per annum (computed
on the basis of a 360-day year, actual days elapsed) equal to nine percent (9%) above the rate of interest from time to time applicable
to this Note (the “Default Rate”).

 

REPAYMENT
AND PREPAYMENT:

 

(a)       Monthly
Repayment. On each Payment Date commencing after September 1, 2021, in addition to payments of interest described above, the
borrower shall also make payments on the Principal Amount of the Loan equal to 1/36 of the then outstanding Principal Amount.
The amount of said monthly payments is equal to the amount required to amortize fully the outstanding Principal Amount of the
Loan, together with interest, over a period of thirty six (36) months.

 

(b)       Maturity
Date. The entire remaining unpaid Principal Amount of this Note, together with all accrued and unpaid interest thereon and
all other amounts payable hereunder, shall be due and payable, if not sooner paid, on September 30, 2022 or an earlier date as
a result of a maturity, whether by acceleration or otherwise, pursuant to the terms hereof (the “Maturity Date”).

 

(c)       Payments
Due Other than on a Business Day. If this Note or any payment hereunder becomes due on a day which is not a business day,
the due date of this Note or payment shall be extended to the next succeeding business day, and such extension of time shall be
included in computing interest in connection with such payment.

 

    	- 2 -

     

    

 

(d)       Prepayment.
This Note may be prepaid in full or in part at any time without penalty or premium.

 

(e)       Application
of Payments. All payments received by the Secured Party shall be applied first to accrued interest, fees, expenses, and other
amounts due to the Secured Party (excluding principal) as the Secured Party determines in its sole discretion, and the balance
on account of outstanding principal.

 

REPRESENTATIONS
AND WARRANTIES:

 

The
Debtor represents and warrants to the Secured Party that:

 

(a)       the
Debtor is duly organized, validly existing, and in good standing under the laws of, and is fully qualified and authorized to do
business in, the state of its organization and is in good standing, and is fully qualified and authorized to do business in, all
other jurisdictions where that authorization or qualification is required;

 

(b)       the
Debtor has full power and authority to engage in all of the transactions contemplated by the Note and has full power, authority,
and legal right to execute and deliver, and to comply with its obligations under, the Note, which constitutes the legally binding
obligation of the Debtor enforceable against the Debtor in accordance with its terms;

 

(c)       the
Debtor has taken all necessary action to duly authorize the execution, delivery, and performance of the Note;

 

(d)       the
Debtor’s execution and delivery of the Note, and grant of security and collateral relating thereto, will not conflict with
or result in a breach of any of the provisions of the organizational documents of the Debtor, or of any applicable law, judgment,
order, writ, injunction, decree, rule, or regulation of any court, administrative agency, or other governmental authority, or
of any agreement or other instrument to which the Debtor is a party or by which the Debtor is bound, or constitute a default under
any of the foregoing;

 

(e)       the
Debtor has good and marketable title to, and is the owners of, all collateral given as security to the Secured Party hereunder,
and all of such collateral is free and clear of pledges, liens, security interests, and other encumbrances, other than those existing
as of the date hereof or in favor of the Secured Party; and

 

(f)       the
Debtor is an entity of the type, and is formed under the laws of the jurisdiction, set forth in the heading of this Note; and
its true, correct, and complete legal name as it appears on its organizational documents is as set forth in the heading of this
Note.

 

NEGATIVE
COVENANTS:

 

Unless
the Secured Party otherwise consents in writing, the Debtor covenants and agrees that the Debtor shall not:

 

    	- 3 -

     

    

 

(a)       Changes
in Form. (i) sell, transfer, finance, lease, license, or dispose of all or substantially all of its property or assets, liquidate,
windup, or dissolve; (ii) acquire all or substantially all of the property or assets of, or the equity interests in, any other
person; (iii) participate in any merger, consolidation, share exchange, division, conversion, reclassification, or other absorption
or reorganization; (iv) purchase, redeem, acquire, or retire any equity interest in it; (v) create or acquire any subsidiary;
(vi) change its legal form or name; (vii) change its jurisdiction of organization or become (or attempt or purport to become)
organized in more than one jurisdiction; or (viii) amend, modify, or supplement its organizational or governing documents; and

 

(b)       Liens.
except for those existing as of the date hereof or in favor of the Secured Party, create, incur, assume, permit, or suffer to
exist any pledges, liens, security interests, and other encumbrances of its property or assets, whether now owned or hereafter
owned or acquired.

 

(c)       Indebtedness.
except for the indebtedness incurred under this Note, create, incur or permit to exist any debt that is senior to, or pari passu
with this Note.

 

SECURITY
AGREEMENT:

 

(a)       Definitions.

 

(i)       “Change
of Control” shall mean (a) any person or group of persons within the
meaning of § 13(d)(3) of the Securities Exchange Act of 1934 becomes the beneficial owner, directly or indirectly, of 33%
or more of the outstanding Equity Interests of Predictive Technology Group, Inc. (“Parent”), (b) individuals who constitute
the directors of the Parent or the Debtor cease for any reason to constitute at least a majority of the board of directors thereof
or (c) Parent shall cease to own and control, of record and beneficially, one hundred percent (100%) of each class of outstanding
Equity Interests of the Debtor free and clear of all Liens (except Liens created by hereunder or under loans between the Debtor
and the Secured Party).

 

(ii)       “Equity
Interests” shall mean, with respect to any person, all of the shares of capital stock of (or other ownership or profit interests
in) such person, all of the warrants, options or other rights for the purchase or acquisition from such person of shares of capital
stock of (or other ownership or profit interests in) such person, all of the securities convertible into or exchangeable for shares
of capital stock of (or other ownership or profit interests in) such person or warrants, rights or options for the purchase or
acquisition from such person of such shares (or such other interests), and all of the other ownership or profit interests in such
person (including partnership, member or trust interests therein), whether voting or nonvoting, and whether or not such shares,
warrants, options, rights or other interests are outstanding on any date of determination.

 

(iii)       
“UCC” shall mean Article 9 of the Uniform Commercial Code, as in effect from time to time in the state of Delaware;
provided, however, that in the event that by reason of mandatory provisions of any applicable law, any of the attachment, perfection,
or priority the Secured Party’s security interest in any collateral is governed by the Uniform Commercial Code of a jurisdiction
other than such state, “UCC” shall mean the Uniform Commercial Code as in effect in such other jurisdiction for purposes
of the provisions hereof relating to such attachment, perfection, or priority and for purposes of the definitions related to or
otherwise used in such provisions.

 

    	- 4 -

     

    

 

(iv)       The
following terms have the meanings given to them in the UCC (such meanings to be equally applicable to both the singular and plural
forms of the terms defined): “account,” “accession,” “account debtor,” “chattel paper,”
“commercial tort claim,” “commodity contract,” “deposit account,” “electronic chattel
paper,” “equipment,” “fixture,” “general intangible,” “goods,” “instruments,”
“inventory,” “investment property,” “letter-of-credit right,” “proceeds,” “record,”
“securities account,” “security,” “supporting obligation,” and “tangible chattel paper.”

 

(b)       Security
Interest. The Debtor hereby grants to the Secured Party a continuing security interest (the “Security Interest”)
in the following property and assets of the Debtor, whether now owned or at any time hereafter acquired by the Debtor or in which
the Debtor now has or at any time in the future may acquire any right, title, or interest, wherever located, and whether now existing
or hereafter acquired or created:

 

i.       all
accounts;

 

ii.       all
fees received by Debtor in respect of the COVID-19 tests administered by the Debtor and/or its affiliates;

 

iii.       all
supporting obligations thereof and all increases or profits received therefrom, all software, books, and records related thereto,
and all parts, accessories, special tools, attachments, additions, accessions, replacements, and substitutions thereto or therefor;
and

 

iv.       and
all cash and non-cash proceeds of any of the foregoing in any form (including, without limitation, insurance proceeds).

 

(c)       Obligations
Secured. The Security Interest granted by the Debtor secures the full payment and performance of all obligations of the Debtor
to the Secured Party under this Note.

 

(d)       Further
Assurances. The Debtor agrees that from time to time, at the expense of the Debtor, the Debtor will promptly execute and deliver
all further instruments and documents, and take all further action, that may be necessary or desirable, or that the Secured Party
may reasonably request, in order to perfect and protect any pledge, assignment or security interest granted or purported to be
granted hereby or to enable the Secured Party to exercise and enforce its rights and remedies hereunder with respect to any collateral.
Without limiting the generality of the foregoing, the Debtor will execute and file such instruments or notices, as may be necessary
or desirable, or as the Secured Party may request, in order to perfect and preserve the pledge, assignment and security interest
granted or purported to be granted hereby. The Debtor hereby authorizes the Secured Party to file one or more financing or continuation
statements, and amendments thereto, relating to all or any part of the collateral without the signature of the Debtor where permitted
by law. A photocopy or other reproduction of this Note or any financing statement covering the collateral or any part thereof
shall be sufficient as a financing statement where permitted by law.

 

    	- 5 -

     

    

 

EVENTS
OF DEFAULT:

 

The
occurrence of any of the following shall constitute an “Event of Default” under this Note:

 

(a)       the
failure to pay when due any principal, interest, fees, or other charges hereunder, which failure remains uncured for two (2) days;

 

(b)       any
default in the performance of or compliance with any covenants set forth in this Note, which default remains uncured for five
(5) days;

 

(c)       any
representation or warranty made by Debtor to the Secured Party in this Note is false, erroneous, or misleading; and

 

(d)       a
Change of Control shall occur.

 

MISCELLANEOUS:

 

(a)       Remedies.
Upon the occurrence of any Event of Default, without demand of performance or other demand, presentment, protest, advertisement,
or notice of any kind (except any notice required by law) to or upon the Debtor or any other person (all and each of which demands,
presentments, protests, advertisements and notices are hereby waived), the holder of this Note, at the holder’s option,
may exercise any right, power, or remedy permitted by law or as set forth herein and, without limiting the generality of the foregoing,
may declare the entire unpaid principal amount hereof and all interest accrued hereon, and all other sums owed under, or secured
by, this Note to be, and such principal, interest, and other sums shall thereupon become, immediately due and payable in full
in immediately available funds. The failure by the Secured Party to exercise the acceleration option shall not constitute a waiver
of its right to exercise the acceleration option at any other time so long as that Event of Default remains outstanding and uncured
or to exercise it upon the occurrence of another Event of Default.

 

(b)       Rights
of the Secured Party; Rights Cumulative. The rights and remedies of the Secured Party as provided herein shall be cumulative
and concurrent and may be pursued singly, successively, or together against the Debtor or any collateral, at the sole discretion
of the Secured Party; and the failure to exercise any such right or remedy shall in no event be construed as a waiver or release
of the same. The Secured Party shall not by any act of omission or commission be deemed to waive any of its rights or remedies
under this Note unless such waiver is in writing and signed by the Debtor, and then only to the extent specifically set forth
therein; and a waiver of one event shall not be construed as continuing or as a bar to or waiver of such right or remedy upon
a subsequent event. The Secured Party shall not be required to marshal any present or future security for, or guarantees of, this
Note or to resort to any such security or guarantee in any particular order, and the Debtor waives, to the fullest extent that
it lawfully can, (i) any right it might have to require the Secured Party to pursue any particular remedy before proceeding against
the Debtor and (ii) any right to the benefit of, or to direct the application of, the proceeds of any collateral until this Note
is repaid in full. If at any time all or any part of any payment applied by the Secured Party to any indebtedness or liability
of the Debtor under this Note is or must be rescinded or returned by the Secured Party for any reason whatsoever (including without
limitation the insolvency, bankruptcy, or reorganization of the Debtor) such indebtedness or liability shall for the purpose of
this Note, to the extent that such payment is or must be rescinded or returned, be deemed to have continued in existence notwithstanding
such application by the Secured Party, and this Note shall continue to be effective or be reinstated, as the case may be, as to
such indebtedness or liability as though such application by the Secured Party had not been made.

 

    	- 6 -

     

    

 

(c)       Fees
and Costs. The Debtor shall pay to the holder immediately upon demand the full amount of all payments, advances, charges,
costs and expenses, including reasonable attorneys’ fees, expended or incurred by the holder in connection with the drafting,
negotiation, enforcement of the holder’s rights and/or the collection of any amounts which become due to the holder under
this Note (provided that, the attorney’s fees in connection with the drafting and negotiation of this Note shall in no event
exceed $7,500, which amount shall be deducted from the Loan proceeds paid to the Debtor on the date hereof), and the prosecution
or defense of any action in any way related to this Note, including without limitation, any action for declaratory relief, whether
incurred at the trial or appellate level, in an arbitration proceeding or otherwise, and including any of the foregoing incurred
in connection with any bankruptcy proceeding (including, without limitation, any adversary proceeding, contested matter, or motion
brought by the holder or any other person) relating to the Debtor or any other person or entity.

 

(d)       Governing
Law. This Note shall be governed by and construed in accordance with the laws of the State of Delaware, without reference
to the conflicts of law or choice of law principles thereof.

 

(e)       Amendments.
This Note shall not be altered, amended, or modified by course of dealing, other conduct, or oral agreement or representation
(whether or not supported by consideration) made before or after the execution of this Note. All amendments or changes of any
kind must be in writing, executed by the Debtor and the Secured Party.

 

(f)       Assignments.
The Secured Party shall have the unrestricted right at any time and from time to time, and without the Debtor’s consent,
to sell, assign, endorse, or transfer all or any portion of its rights and obligations hereunder. This Note is a binding obligation
enforceable against the Debtor and its successors and assigns and shall inure to the benefit of the Secured Party and its successors
and assigns. Notwithstanding the foregoing, the Debtor shall not assign its obligations hereunder, or any interest herein, without
obtaining the prior written consent of the Secured Party, and any assignment or attempted assignment by the Debtor without the
Secured Party’s prior written consent will be void and of no effect with respect to the Secured Party.

 

(g)       Notices.
Any demand or notice hereunder or under any applicable law pertaining hereto shall be in writing and duly given if delivered to
the Debtor (at its address set forth in the heading of this Note) or to the Secured Party (at its address set forth in the heading
of this Note). A notice shall, for all purposes, be deemed given and received: (i) if hand delivered to a party against receipted
copy, when the copy of the notice is receipted; (ii) if given by a nationally recognized and reputable overnight delivery service
company, the day on which the notice is delivered by the delivery service company to such party; or (iii) if given by certified
mail, two (2) business days after it is posted with the United States Postal Service.

 

    	- 7 -

     

    

 

(h)       Waiver
of Jury Trial. The Debtor knowingly, voluntarily, and intentionally waives the rights it may have to a trial by jury in respect
to any litigation based hereon, or arising out of, under, or in connection with this Note, any document contemplated to be executed
in connection with this Note, or any underlying matter, course of dealing, statement (whether verbal or written), or action (each
an “Action”).

 

(i)       Consent
to Jurisdiction and Service of Process. The Debtor knowingly, voluntarily, and intentionally (i) consents in each Action commenced
by the Secured Party to the nonexclusive personal jurisdiction of any court that is either a court of record of the State of Delaware
or a court of the United States of America located in the State of Delaware, (ii) waives each objection to the laying of venue
of any such Action and any claim that such Action has been brought in an inconvenient forum, (iii) waives personal service of
process in each such Action, and (iv) consents to the making of service of process in each such Action by registered mail directed
to the Debtor at the last address of the Debtor shown in the records relating to this Note maintained by the Secured Party, with
such service of process to be deemed completed five (5) days after the mailing thereof. Notwithstanding the foregoing, the Secured
Party, in its sole and absolute discretion, may initiate an Action in the courts of any other jurisdiction in which the Debtor
may be found or in which any property or asset of the Debtor may be located.

 

(j)       Savings
Clause. The agreements made by the Debtor with respect to this Note are expressly limited so that in no event shall the amount
of interest received, charged, or contracted for by the Secured Party exceed the highest lawful amount of interest permissible
under the laws applicable to the Loan. If at any time performance of any provision of this Note results in the highest lawful
rate of interest permissible under applicable laws being exceeded, then the amount of interest received, charged, or contracted
for by the Secured Party shall automatically and without further action by any party be deemed to have been reduced to the highest
lawful amount of interest then permissible under applicable laws. If the Secured Party shall ever receive, charge, or contract
for, as interest, an amount which is unlawful, at the Secured Party’s election, the amount of unlawful interest shall be
refunded to the Debtor (if actually paid) or applied to reduce the then unpaid amount of this Note. To the fullest extent permitted
by applicable law, any amounts contracted for, charged, or received under this Note included for the purpose of determining whether
the interest rate would exceed the highest lawful rate shall be calculated by allocating and spreading such interest to and over
the full stated term of this Note.

 

[SIGNATURE
PAGES FOLLOW]

 

    	- 8 -

     

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Note, with the intention that it constitute an instrument under seal, and intending
to be legally bound hereby, as of the date first written above.

 

	 	Predictive
    LABORATORIES, Inc.,
    a Utah corporation, as Debtor
	 	 	 
	 	By:	/s/
    Bradley Robinson
	 	Name:	Bradley
    Robinson
	 	Title:	Director
	 	 	 
	 	PROPHASE
    LABS, INC., a Delaware corporation, as Secured Party
	 	 	 
	 	By:	/s/
    Ted Karkus
	 	Name:	Ted
    Karkus
	 	Title:	Chief
    Executive Officer

 

    	- 9 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]